97 related articles for article (PubMed ID: 22585169)
21. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD
Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407
[TBL] [Abstract][Full Text] [Related]
22. Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4.
Jackson-Fisher AJ; Bellinger G; Shum E; Duong JK; Perkins AS; Gassmann M; Muller W; Kent Lloyd KC; Stern DF
Oncogene; 2006 Sep; 25(41):5664-72. PubMed ID: 16652155
[TBL] [Abstract][Full Text] [Related]
23. Developmental timing of activated erbB2 expression plays a critical role in the induction of mammary tumors.
Andrechek ER; Muller WJ
Cell Cycle; 2004 Sep; 3(9):1111-3. PubMed ID: 15326381
[TBL] [Abstract][Full Text] [Related]
24. Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system.
Croci S; Recktenwald CV; Lichtenfels R; Nicoletti G; Dressler SP; De Giovanni C; Astolfi A; Palladini A; Shin-ya K; Landuzzi L; Nanni P; Lollini PL; Seliger B
Proteomics; 2010 Nov; 10(21):3835-53. PubMed ID: 20957756
[TBL] [Abstract][Full Text] [Related]
25. Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling.
Hodgson JG; Malek T; Bornstein S; Hariono S; Ginzinger DG; Muller WJ; Gray JW
Cancer Res; 2005 Nov; 65(21):9695-704. PubMed ID: 16266989
[TBL] [Abstract][Full Text] [Related]
26. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice.
Quan L; Dittmar A; Zhou Y; Hutson A; Stassen AP; Demant P
Genes Chromosomes Cancer; 2012 Jul; 51(7):631-43. PubMed ID: 22419448
[TBL] [Abstract][Full Text] [Related]
28. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
29. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.
Reddy KB; McGowen R; Schuger L; Visscher D; Sheng S
Oncogene; 2001 Oct; 20(45):6538-43. PubMed ID: 11641778
[TBL] [Abstract][Full Text] [Related]
30. Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors.
Wakefield A; Soukupova J; Montagne A; Ranger J; French R; Muller WJ; Clarkson RW
Cancer Res; 2013 Jan; 73(2):745-55. PubMed ID: 23149915
[TBL] [Abstract][Full Text] [Related]
31. Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2.
Davis VL; Jayo MJ; Ho A; Kotlarczyk MP; Hardy ML; Foster WG; Hughes CL
Cancer Res; 2008 Oct; 68(20):8377-83. PubMed ID: 18922910
[TBL] [Abstract][Full Text] [Related]
32. Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis.
Liu S; Liu W; Jakubczak JL; Erexson GL; Tindall KR; Chan R; Muller WJ; Adhya S; Garges S; Merlino G
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3770-5. PubMed ID: 11867754
[TBL] [Abstract][Full Text] [Related]
33. Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.
Boulay PL; Mitchell L; Turpin J; Huot-Marchand JÉ; Lavoie C; Sanguin-Gendreau V; Jones L; Mitra S; Livingstone JM; Campbell S; Hallett M; Mills GB; Park M; Chodosh L; Strathdee D; Norman JC; Muller WJ
Cancer Res; 2016 May; 76(9):2662-74. PubMed ID: 26933086
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
35. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
37. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ
Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082
[TBL] [Abstract][Full Text] [Related]
38. Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation.
Raghuram N; Temel EI; Kawamata T; Kozma KJ; Loch AJ; Wang W; Adams JR; Muller WJ; Egan SE
Breast Cancer Res; 2024 May; 26(1):86. PubMed ID: 38807216
[TBL] [Abstract][Full Text] [Related]
39. Stat1 is a suppressor of ErbB2/Neu-mediated cellular transformation and mouse mammary gland tumor formation.
Raven JF; Williams V; Wang S; Tremblay ML; Muller WJ; Durbin JE; Koromilas AE
Cell Cycle; 2011 Mar; 10(5):794-804. PubMed ID: 21311224
[TBL] [Abstract][Full Text] [Related]
40. Targeting janus kinase 2 in Her2/neu-expressing mammary cancer: Implications for cancer prevention and therapy.
Sakamoto K; Lin WC; Triplett AA; Wagner KU
Cancer Res; 2009 Aug; 69(16):6642-50. PubMed ID: 19638583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
